Window of opportunity trial of neoadjuvant olaparib and durvalumab for triple negative or low ER-positive breast cancer

被引：0
|
作者：
Im, Seock-Ah
Lee, Kyung-Hun
Min, Ahrum
Lee, Daewon
Kim, Tae Yong
Ryu, Han Suk
Koh, Jiwon
Cheon, Gi-Jeong
Shin, Yoon-Jung
Kim, Yujin
Moon, Hyeong-Gon
Han, Wonshik
Lee, Han-Byoel
Diolaiti, Morgan
Quigley, David
Ashworth, Alan
Cho, Nariya
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-PD15-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD15-08
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PARTNER Trial: Neoadjuvant olaparib in triple negative breast cancer (TNBC)
    Abraham, Jean E.
    Pinilla, Karen
    Grybowicz, Louise
    Dayimu, Alimu
    Demiris, Nikolaos
    Harvey, Caron
    Drewett, Lynsey M.
    Lucey, Rebecca
    Fulton, Alexander
    Roberts, Anne N.
    Worley, Joanna R.
    Chhabra, Anita
    Qian, Wendi
    Hardy, Richard M.
    Chan, Stephen
    Hickish, Tamas
    Tripathi, Devashish
    Venkitaraman, Ramachandran
    Persic, Mojca
    Aslam, Shahzeena
    Glassman, Daniel
    Raj, Sanjay
    Borley, Annabel
    Braybrooke, Jeremy P.
    Sutherland, Stephanie
    Staples, Emma
    Scott, Lucy C.
    Davies, Mark
    Palmer, Cheryl A.
    Moody, Margaret
    Churn, Mark J.
    Newby, Jacqueline C.
    Mukesh, B. Mukesh
    Chakrabarti, Amitabha
    Roylance, Rebecca R.
    Schouten, Philip C.
    Levitt, Nicola
    McAdam, Karen
    Armstrong, Anne C.
    Copson, Ellen R.
    McMurtry, Emma
    Tischkowitz, Marc
    Provenzano, Elena
    Earl, Helena
    [J]. CANCER RESEARCH, 2024, 84 (07)
  • [2] NOBLE Neoadjuvant Olaparib and Durvalumab for patients with BRCA-associated TripLE Negative Breast Cancer
    Buhrer, Emanuel
    Xenophontos, Eleni
    Hamy-Petit, Anne-Sophie
    Casas-Martin, Jose
    Callens, Celine
    Meyskens, Thomas
    Poncet, Coralie
    Lanzi, Anastasia
    Brain, Etienne
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [3] The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
    Abraham, Jean E.
    Pinilla, Karen
    Dayimu, Alimu
    Grybowicz, Louise
    Demiris, Nikolaos
    Harvey, Caron
    Drewett, Lynsey M.
    Lucey, Rebecca
    Fulton, Alexander
    Roberts, Anne N.
    Worley, Joanna R.
    Chhabra, Anita
    Qian, Wendi
    Vallier, Anne-Laure
    Hardy, Richard M.
    Chan, Steve
    Hickish, Tamas
    Tripathi, Devashish
    Venkitaraman, Ramachandran
    Persic, Mojca
    Aslam, Shahzeena
    Glassman, Daniel
    Raj, Sanjay
    Borley, Annabel
    Braybrooke, Jeremy P.
    Sutherland, Stephanie
    Staples, Emma
    Scott, Lucy C.
    Davies, Mark
    Palmer, Cheryl A.
    Moody, Margaret
    Churn, Mark J.
    Newby, Jacqueline C.
    Mukesh, Mukesh B.
    Chakrabarti, Amitabha
    Roylance, Rebecca R.
    Schouten, Philip C.
    Levitt, Nicola C.
    Mcadam, Karen
    Armstrong, Anne C.
    Copson, Ellen R.
    Mcmurtry, Emma
    Tischkowitz, Marc
    Provenzano, Elena
    Earl, Helena M.
    [J]. NATURE, 2024, 629 (8014) : 1142 - 1148
  • [4] Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial
    Schettini, Francesco
    Corona, Silvia Paola
    Giudici, Fabiola
    Strina, Carla
    Sirico, Marianna
    Bernocchi, Ottavia
    Milani, Manuela
    Ziglioli, Nicoletta
    Aguggini, Sergio
    Azzini, Carlo
    Barbieri, Giuseppina
    Cervoni, Valeria
    Cappelletti, Maria Rosa
    Molteni, Alfredo
    Lazzari, Maria Chiara
    Ferrero, Giuseppina
    Ungari, Marco
    Marasco, Elena
    Bruson, Alice
    Xumerle, Luciano
    Zago, Elisa
    Cerra, Davide
    Loddo, Marco
    Williams, Gareth H.
    Paris, Ida
    Scambia, Giovanni
    Generali, Daniele
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] ARB: Phase II window of opportunity study of short-term preoperative treatment with enzalutamide in ER-positive and triple-negative breast cancer
    Schmid, Peter
    Wheatley, Duncan A.
    Thompson, Alastair Mark
    Roy, Pankaj
    Bundred, Nigel J.
    Purushotham, Anand David
    McIntosh, Stuart
    Kummel, Sherko
    Harbeck, Nadia
    Nitz, Ulrike
    Barnes, David
    Sarker, Shah-Jalal
    Mousa, Kelly
    Cortes, Javier
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Claudin Expression in Triple Negative and ER-Positive Breast Carcinoma
    Malik, M. A.
    Cohen, C.
    Adams, A.
    Wang, J.
    Oprea, G. M.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 56A - 56A
  • [7] Claudin Expression in Triple Negative and ER-Positive Breast Carcinoma
    Malik, M. A.
    Cohen, C.
    Adams, A.
    Wang, J.
    Oprea, G. M.
    [J]. MODERN PATHOLOGY, 2013, 26 : 56A - 56A
  • [8] The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer
    Fjermeros, Kamilla
    Ghannoum, Salim
    Geisler, Stephanie B.
    Bhargava, Sameer
    Tahiri, Andliena
    Klajic, Jovana
    Luders, Torben
    Fongard, Marie
    Nawaz, Meh Sameen
    Bosnjak-Olsen, Tatjana
    Buvarp, Unn-Cathrin Edvardsen
    Johanna Rosenskiold, Aino Katri
    Nguyen, Nam Thi
    Sletbak, Tone Tysko
    Seyedzadeh, Manouchehr
    Selsas, Knut
    Porojnicu, Alina Carmen
    Skjerven, Helle Kristine
    Hovda, Tone
    Sahlberg, Kristine Kleivi
    Torland, Lilly Anne
    Lyngra, Marianne
    Hammarstrom, Clara Louise
    Honigsperger, Elma Bahonjic
    Noone, John Christopher
    Mathiassen, Silje
    Hurtado, Antoni
    Goel, Shom
    Koff, Andrew
    Tekpli, Xavier
    Kristensen, Vessela N.
    Geisler, Juergen
    [J]. FUTURE ONCOLOGY, 2024,
  • [9] Neoadjuvant olaparib monotherapy in primary triple negative breast cancer
    Eikesdal, H. P.
    Yndestad, S.
    Blix, E. S.
    Lundgren, S.
    Vagstad, G.
    Espelid, H.
    Gilje, B.
    Janssen, E. A.
    Geisler, J.
    Aas, T.
    Aase, H.
    Knappskog, S.
    Lonning, P. E.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [10] Low Estrogen Receptor ( ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy Is Response Similar to Typical ER-Positive or ER-Negative Disease?
    Landmann, Alessandra
    Farrugia, Daniel J.
    Zhu, Li
    Diego, Emilia J.
    Johnson, Ronald R.
    Soran, Atilla
    Dabbs, David J.
    Clark, Beth Z.
    Puhalla, Shannon L.
    Jankowitz, Rachel C.
    Brufsky, Adam M.
    Ahrendt, Gretchen M.
    McAuliffe, Priscilla F.
    Bhargava, Rohit
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 (01) : 34 - 42
12345